Synta to Host Conference Call and Webcast of Third Quarter 2013 Financial
Results on November 4, 2013
LEXINGTON, Mass. -- October 29, 2013
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will report
its third quarter 2013 financial results on Monday, November 4, 2013, before
Following the announcement, management will host a conference call and webcast
at 10:00 a.m. ET that morning to discuss the third quarter results and provide
The conference call can be accessed by dialing (877) 407-8035 (U.S.) or (201)
689-8035 (International). For those unable to join the live call, a replay
will be available from 2:00 p.m. ET on November 4 through 11:59 p.m. ET on
November 11. To access the replay, please dial (877) 660-6853 (U.S.) or (201)
612-7415 (International) and refer to conference ID 100513.
The live webcast can be accessed by visiting the Investor Relations section of
the Synta Pharmaceuticals website, www.syntapharma.com. The webcast will also
be archived under Webcasts and Events within the Investor Relations section of
the Company's website.
About Synta Pharmaceuticals
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on
discovering, developing, and commercializing small molecule drugs to extend
and enhance the lives of patients with severe medical conditions, including
cancer and chronic inflammatory diseases. Synta has a unique chemical compound
library, an integrated discovery engine, and a diverse pipeline of clinical-
and preclinical-stage drug candidates with distinct mechanisms of action and
novel chemical structures. All Synta drug candidates were invented by Synta
scientists using our compound library and discovery capabilities. For more
information, please visit www.syntapharma.com.
Synta Pharmaceuticals Corp.
George Farmer, 781-541-7213
Andrea Rabney, 212-600-1494
Press spacebar to pause and continue. Press esc to stop.